Atlas Research is pleased to announce the arrival of Eduardo Ortiz, MD, MPH as medical director. Dr. Ortiz is board-certified in internal medicine and contributes his expertise in evidence-based medicine, systematic review methodology, guideline development, quality and safety, quality measures, informatics, and outcomes research to a variety of federal projects.
Before joining Atlas Research, Dr. Ortiz was director of Clinical Development and Informatics at ProVation Medical, Wolters Kluwer Health, where he led the clinical content and development team for ProVation Order Sets, which have been used in over 700 hospitals, outpatient facilities, and emergency departments nationally and internationally. He was previously a senior medical officer in the Division for the Application of Research Discoveries with the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health, focusing on translating research into clinical practice and the development and implementation of evidence-based guidelines. He also served as an NHLBI representative on a variety of multidisciplinary committees, a liaison to numerous organizations, and a senior advisor in the Center for Biomedical Informatics.
Other positions Dr. Ortiz has held include associate chief of staff, director of clinical informatics, and attending physician on the inpatient and outpatient clinical services at the Washington DC VA Medical Center; senior fellow and senior advisor for clinical informatics at the Agency for Healthcare Research and Quality; attending physician and research scientist at the VA San Diego Healthcare System; investigator with the VA-RAND Health Sciences Program; San Diego site director of the Southern California Evidence-Based Practice Center; and associate director of Outcomes Research and Management, U.S. Medical and Scientific Affairs at Merck and Co., Inc.
Dr. Ortiz has held academic faculty appointments at the Johns Hopkins School of Medicine, Harvard Medical School, The George Washington University School of Medicine, and the University of California, San Diego School of Medicine.
“The addition of Dr. Ortiz to the Atlas Team aligns with our commitment to working with a broad range of public and private stakeholders to improve the quality and delivery of health care,” said Atlas Research CEO Ryung Suh, MD, MPP, MBA, MPH. “He shares our passion for identifying solutions that are based on sound evidence, and his leadership and expertise are a welcome addition to the firm.”